EssilorLuxottica (OTCMKTS:ESLOY) Hits New 1-Year Low – Should You Sell?

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report) hit a new 52-week low during trading on Thursday . The company traded as low as $89.74 and last traded at $90.09, with a volume of 13054 shares changing hands. The stock had previously closed at $92.12.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ESLOY. The Goldman Sachs Group lowered shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of EssilorLuxottica in a research note on Tuesday, May 12th. They issued a “hold” rating on the stock. Finally, Zacks Research upgraded EssilorLuxottica from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, EssilorLuxottica currently has a consensus rating of “Moderate Buy”.

Get Our Latest Report on ESLOY

EssilorLuxottica Stock Performance

The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. The firm’s 50-day moving average price is $95.30 and its two-hundred day moving average price is $106.48.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

See Also

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.